NECFA
SRNE

New England Capital Financial Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

New England Capital Financial Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,900
Closed -$6.43K – 450
2022
Q4 		$6.43K Buy
+5,900
New +$6.43K ﹤0.01% 277